CN110302303A - It is a kind of for treating the Chinese medicine composition of rheumatism and fracture - Google Patents
It is a kind of for treating the Chinese medicine composition of rheumatism and fracture Download PDFInfo
- Publication number
- CN110302303A CN110302303A CN201910724453.1A CN201910724453A CN110302303A CN 110302303 A CN110302303 A CN 110302303A CN 201910724453 A CN201910724453 A CN 201910724453A CN 110302303 A CN110302303 A CN 110302303A
- Authority
- CN
- China
- Prior art keywords
- fracture
- medicine
- chinese medicine
- rheumatism
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a kind of for treating the Chinese medicine composition of rheumatism and fracture, is impregnated in white wine by following Chinese medicine: in the white wine of every 100g, only containing safflower 1.5g, dragon's blood 1g, olibanum 1g, myrrh 1g, folium artemisiae argyi 2g and elder 1g.This medicine is very significant to the curative effect of traumatic injury and rheumatic arthritis, and finds that this medicine also has certain curative effect to the symptom for alleviating rheumatoid；Meanwhile also there is good curative effect to the recovery of fracture.And the safflower of use, dragon's blood, olibanum, myrrh, folium artemisiae argyi, elder are essentially the lesser Chinese medicinal material of nontoxic or toxicity, toxic side effect is small, and medicinal material type is few and smart, therefore small to internal organ burden, and reduces cost of manufacture.
Description
Technical field
The invention belongs to the field of Chinese medicines, and in particular to a kind of for treating the Chinese medicine composition of rheumatism.
Background technique
Rheumatic arthritis, rheumatoid arthritis in western medicine, osteoarthritis, rheumatic fever, sciatica, lumbar vertebrae
Illnesss, the Chinese medicines such as disk protrusion are referred to as rheumatism.Rheumatism is to invade human body by exopathogens such as wind, cold, wet, heat, causes QI-blood circulation
Unsmooth, obstruction of meridians and collaterals is caused to be ached with muscle, muscles and bones, joint, numbness, be weighed, joint stuffiness, even arthrocele is burnt
Heat etc. are the illness of main clinical manifestation.
For doctor trained in Western medicine when treating rheumatism, used Western medicine is easy to allow human body to generate dependence, Yi Fanfu after drug withdrawal, and to people
The side effect of body liver kidney is larger.
Traditional Chinese Medicine has experience abundant in rheumatism research, and Chinese medicine reaches mark from disease entirety, diagnosis and treatment
This simultaneous purpose controlled.
In addition, reset, fixation and rehabilitation that modern fractures generally use, it is longer that there are the courses for the treatment of, patient suffering
The problem of time length.
Summary of the invention
Existing for western medical treatment rheumatism easily allows human body to generate dependence, Yi Fanfu after drug withdrawal, and to the pair of human liver kidney
Act on larger and fractures period longer problem, it is an object of the present invention to provide it is a kind of treat rheumatism, fracture effect it is good
Chinese medicine.
Based on above-mentioned purpose, technical scheme is as follows:
It is a kind of for treating the Chinese medicine composition of rheumatism and fracture, impregnated in white wine by following Chinese medicine: every 100g
White wine in, only contain safflower 1.5g, dragon's blood 1g, olibanum 1g, myrrh 1g, folium artemisiae argyi 2g and elder 1g.
The degree of the white wine is more than or equal to 50 degree, it is preferred that the degree of the white wine is 52 degree.
Chinese medicine of the present invention is vertebration, compatibility science, not its compatibility of changeable and weight ratio, to guarantee to treat in the present invention
On the basis of curative effect, using the medicinal material of type, reduction side effect reduce human body viscera burden, and reduce the medicine group less enough
Close the cost of manufacture of object.
Wherein, the safflower of this medicine, it is acrid in flavour and warm in nature.Converge to heart and liver channels.Blood circulation, removing blood stasis and acesodyne；
Dragon's blood, it is sweet, salty, it puts down.Converge to heart and liver channels.Promoting blood circulation analgesic therapy, removing blood stasis and hemostasis, myogenic sore；
Olibanum, pungent, bitter, temperature.Return heart, liver, the spleen channel.Promoting blood circulation analgesic therapy, detumescence and promoting granulation；
Myrrh, it is pungent, bitter, it puts down.Return heart, liver, the spleen channel.Scattered stasis pain, detumescence and promoting granulation；
Folium artemisiae argyi, pungent, bitter, temperature.It is slightly poisonous；Return liver,spleen,kidney, warp.Warming channel for arresting bleeding, eliminating cold to stop pain；
Elder, it is sweet, bitter, it puts down.Return liver warp.Dispelling wind and removing obstruction in the meridians, promoting blood circulation and stopping pain, inducing diuresis for removing edema.
The present invention has the beneficial effect that:
Safflower that the present invention uses, dragon's blood, olibanum, myrrh, elder have the benefits of activating microcirculation and removing stasis medicinal, analgesic, therefore can use
In treatment traumatic injury；Wherein, olibanum, myrrh, elder can also be used to treat rheumatic arthralgia, and be added with clearing damp cold dispelling
Folium artemisiae argyi, therefore can be used for treating wind-cold-dampness arthralgia；The elder of use has the benefits of reunion of bone, therefore also has one to the treatment of fracture
Fixed curative effect.Compatibility science of the present invention, above-mentioned medicinal material is put into white wine and is impregnated, the effective component of medicinal material is dissolved in wherein, drug effect
Stablize, and can give full play to, and then improve curative effect, so that the present invention has good effect to the treatment of rheumatism；It uses
Safflower, dragon's blood, olibanum, myrrh, folium artemisiae argyi, elder are essentially the lesser Chinese medicinal material of nontoxic or toxicity, and toxic side effect is small, and medicine
Material type is few but smart, therefore small to internal organ burden, and reduces cost of manufacture；Curative effect of this medicine to traumatic injury and rheumatic arthritis
It is very significant, and find that this medicine also has certain curative effect to rheumatoid symptom is alleviated.
The present invention not only oral administration but also can external application, can be selected according to patient's own situation, wherein doctor need to be abided by when taking this medicine orally
It advises, meanwhile, the present invention disables drug alcohol intolerance person.
Specific embodiment
Below with reference to embodiment, the present invention is described in further detail, but does not constitute to any limit of the invention
System.
The present invention relates to a kind of for treating the Chinese medicine composition of rheumatism and fracture, formula and the production method is as follows:
Safflower 1.5g, dragon's blood 1g, olibanum 1g are added in 52 degree of white wine of every 100g, myrrh 1g, folium artemisiae argyi 2g, elder 1g will
The container for filling above-mentioned material is placed on shady place and stands 30 days, then filtering bottling.
Above-described embodiment uses 52 degree of white wine；Certainly the present invention is not limited to 52 degree of white wine of the present embodiment, white wine degree is big
In equal to 50 degree.
Medicinal material of the present invention proportion can not be changed, and need brewed in strict accordance with its medicinal material component, guarantee that present invention treatment treats
On the basis of effect, using the medicinal material of type, reduction side effect reduce human body viscera burden, and reduce the pharmaceutical composition less enough
The cost of manufacture of object.
In the present invention, healing refers to that pain disappears, and simultaneous phenomenon restores normal；Improvement refers to that pain slows down, adjoint
Symptom improves；It refers in vain without any improvement.
When the cut-off present invention writes, this medicine treats altogether rheumatism 232, wherein prolapse of lumbar intervertebral disc 5, and rheumatoid closes
Section is 1, rheumatic arthritis 105, traumatic injury 121 scorching.
Wherein, prolapse of lumbar intervertebral disc, rheumatic arthritis be all made of be applied with this liquid medicine treated；
Traumatic injury generally uses external application for curing, and the state of an illness is compared with severe one, it is contemplated that for oral administration plus external application therapeutic modality, for oral administration
It need to follow the doctor's advice when this liquid medicine, oral dosage is 2-3 times daily generally at 5-10 grams；
Rheumatoid arthritis need to be followed the doctor's advice when taking this liquid medicine orally using therapeutic modality that is for oral administration plus being applied with, oral dosage one
As at 5-10 grams, it is 2-3 times daily.
Wherein, prolapse of lumbar intervertebral disc cures 5, improves 0, invalid 0；
Rheumatoid arthritis cures 0, improves 1, invalid 0；
Rheumatic arthritis cures 105, improves 0, invalid 0；
Traumatic injury cures 121, improves 0, invalid 0.
This medicine treats altogether fracture 103, general using therapeutic modality that is for oral administration plus being applied with, and doctor need to be abided by when taking this liquid medicine orally
It advises, oral dosage is 2-3 times daily generally at 5-10 grams.
Through counting, by the treatment of this liquid medicine, the treatment cycle fractured at the fracture of rib and clavicle singly located is generally 15
It or so, the treatment cycle of arm (humerus, ulna, radius) fracture at 30 days or so, control by the fracture of thigh bone (femur, tibiofibula)
The period is treated at 60 days or so；Wherein, 103 are cured, is improved 0, invalid 0.
It is some cases that the present invention treats below.
Case 1:
Chen, female, 13 years old, tae kwon do student was often injured during the training period, this medicine is applied at injury, and is pressed
It rubs, same day pain symptom mitigates, and next day, pain symptom disappears.
Case 2:
Zhao, male, 46 years old, P.E. teacher led to two knee hydrops because long-term motion makes joint injury, and two legs are numb,
It can not walk, after going to hospital to check, doctor suggests that operation replacement meniscus might have amputation if the state of an illness further deteriorates
Risk.Zhao is treated, therapeutic modality is as follows through considering using Chinese medicine of the invention:
It takes Traditional Chinese medicinal liquor of the invention orally, and this medicine is applied at injury, after treatment in 15 days, knee hydrops and pain
It disappears, and behind several days of recuperating, it is normal to go to work, and training is participated in student.
Case 3:
The colleague of Zhao, Lee, male, 40 years old, P.E. teacher led to two knees product because long-term motion makes joint injury
Liquid, pain, difficulty in walking, the same method using oral administration and externally use this medicine, treated through 15 days, knee hydrops and pain effect
It disappears, and behind several days of recuperating, it is normal to go to work.
Case 4:
Chen, male 43 years old, easily in spring and autumn season or when having a cold, lead to knee pain, this drug are applied to injury
Place, next day pain symptom mitigate, and continuous use 3 days, pain symptom disappeared.
Case 5:
Zhang 73 years old, suffers from arteriosclerosis and obstruction of lower limbs, and in great pain, difficulty in walking is continuously applied with this medicine 7 days, and massage when in use
Affected part, pain disappear, can normally walk.
Case 6:
Zhang, female, 30 years old, hospital diagnosis was protrusion of lumber intervertebral disc, flank pain and lower limb numbness, was applied with this medicine to trouble
Place, and affected part is massaged when using this medicine, after continuous use 7 days, the symptom of flank pain and lower limb numbness disappears, can be normal
Working work.
Case 7:
Song, female, 43 years old, hospital therapy was rheumatoid arthritis, was cured in Shanghai institute of traditional Chinese medicine, and doctor uses confused happy
(hydroxychloroquine sulfate piece), happy loose (loxoprofen sodium tablets) and Fengshi Gutong capsule treatment, the state of an illness does not improve, and has exacerbation
Trend, trick joint have deformed, and paralysis is poured on bed；Sweet smell that is continuous for oral administration afterwards plus being applied with this medicine 1 year, while doctor's requirement being used
Happy (hydroxychloroquine sulfate piece), happy loose (loxoprofen sodium tablets) and Fengshi Gutong capsule, are changed to one day two by taking three times a day
It is secondary to take, pass through the work that can normally go to work.
Case 8:
Chen, male, 43 years old, meets with a traffic accident, hospital diagnosis result is fracture of rib, contusion of lung and right ligamentum patellae for 14 years
It dampens, when receiving hospitalize, while taking this medicine orally, treated through 15 days, can walk activity, and doctor is checking indices just
Often, hospital stops treatment, and leaves hospital, and compared to same period patient, the treatment recovery period is obviously shortened.
So far, although those skilled in the art will appreciate that present invention has been shown and described in detail herein multiple shows
Example property embodiment still without departing from the spirit and scope of the present invention, still can according to the present disclosure directly
Determine or deduce out many other variations or modifications consistent with the principles of the invention.Therefore, the scope of the present invention is understood that and recognizes
It is set to and covers all such other variations or modifications.
Claims (3)
1. a kind of for treating the Chinese medicine composition of rheumatism and fracture, which is characterized in that impregnated in white wine by following Chinese medicine and
At: in the white wine of every 100g, only contain safflower 1.5g, dragon's blood 1g, olibanum 1g, myrrh 1g, folium artemisiae argyi 2g and elder 1g.
2. according to claim 1 a kind of for treating the Chinese medicine composition of rheumatism and fracture, which is characterized in that described white
The degree of wine is more than or equal to 50 degree.
3. according to claim 2 a kind of for treating the Chinese medicine composition of rheumatism and fracture, which is characterized in that described white
The degree of wine is 52 degree.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910724453.1A CN110302303A (en) | 2019-08-07 | 2019-08-07 | It is a kind of for treating the Chinese medicine composition of rheumatism and fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910724453.1A CN110302303A (en) | 2019-08-07 | 2019-08-07 | It is a kind of for treating the Chinese medicine composition of rheumatism and fracture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110302303A true CN110302303A (en) | 2019-10-08 |
Family
ID=68083183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910724453.1A Pending CN110302303A (en) | 2019-08-07 | 2019-08-07 | It is a kind of for treating the Chinese medicine composition of rheumatism and fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110302303A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1209335A (en) * | 1997-07-11 | 1999-03-03 | 管永春 | Plaster for treating wound |
| CN101530448A (en) * | 2009-04-21 | 2009-09-16 | 季秀群 | External Chinese medicinal plaster for treating traumatic injury |
| CN101693073A (en) * | 2009-10-15 | 2010-04-14 | 沈阳亿灵医药科技有限公司 | Compound caesalpinia pulcherrima spraying agent and preparation method thereof |
| CN104435169A (en) * | 2014-11-26 | 2015-03-25 | 青岛申达高新技术开发有限公司 | Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of traditional Chinese medicine combination |
| CN104491480A (en) * | 2014-11-05 | 2015-04-08 | 周居默 | Rheumatalgia-relieving and collaterals-activating wine and preparation method thereof |
| CN108126078A (en) * | 2018-01-29 | 2018-06-08 | 中牟鸭李骨科医院 | A kind of plaster |
-
2019
- 2019-08-07 CN CN201910724453.1A patent/CN110302303A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1209335A (en) * | 1997-07-11 | 1999-03-03 | 管永春 | Plaster for treating wound |
| CN101530448A (en) * | 2009-04-21 | 2009-09-16 | 季秀群 | External Chinese medicinal plaster for treating traumatic injury |
| CN101693073A (en) * | 2009-10-15 | 2010-04-14 | 沈阳亿灵医药科技有限公司 | Compound caesalpinia pulcherrima spraying agent and preparation method thereof |
| CN104491480A (en) * | 2014-11-05 | 2015-04-08 | 周居默 | Rheumatalgia-relieving and collaterals-activating wine and preparation method thereof |
| CN104435169A (en) * | 2014-11-26 | 2015-03-25 | 青岛申达高新技术开发有限公司 | Traditional Chinese medicine combination for treating bone injury and fracture and preparation method of traditional Chinese medicine combination |
| CN108126078A (en) * | 2018-01-29 | 2018-06-08 | 中牟鸭李骨科医院 | A kind of plaster |
Non-Patent Citations (8)
| Title |
|---|
| 山东中医学院中药方剂教研室编: "《中药方剂学 上册》", 31 March 1976, 山东人民出版社 * |
| 张瑞贤等: "《国医堂养生百草 化痰止咳平喘药 活血化瘀药》", 30 November 2015, 广西科学技术出版社 * |
| 朱坤福: "《中医外治特效疗法》", 31 May 2019, 中医古籍出版社 * |
| 李艳青等: "《中医学专业知识》", 31 January 2013, 世界图书出版公司北京公司 * |
| 赵梁等: "邓晋丰教授对骨折术后的中医辨治经验", 《四川中医》 * |
| 陈虎彪等: "《中草药全真图鉴》", 30 April 2018, 福建科学技术出版社 * |
| 黄小荣等: "《草药治骨伤》", 31 May 1999, 福建科学技术出版社 * |
| 黄海平: "治踝关节扭伤方", 《中国社区医师》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101732588A (en) | Formula of Chinese medicament for treating bodily pain syndrome | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN102552612B (en) | Traditional Chinese medicine for setting fracture | |
| CN100528194C (en) | Medicine for treating femoral head necrosis | |
| CN106511510A (en) | Medicine composition used for treating wind-cold-damp arthralgia and muscle and bone strain | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN102772619B (en) | Traditional Chinese medicine for treating bone impediment | |
| CN104225283B (en) | A kind of oral medicinal herb medicine and plaster for treating cervical vertebra, scapulohumeral periarthritis, protrusion of lumber intervertebral disc, rheumatic arthritis and rheumatoid arthritis | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN110302303A (en) | It is a kind of for treating the Chinese medicine composition of rheumatism and fracture | |
| CN105343221A (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities | |
| CN105327289A (en) | Traditional Chinese medicine composition for treating lumbocrural pain | |
| CN102274372A (en) | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage | |
| CN101502604B (en) | Chinese herbal medicine preparation for treating rheumatism | |
| CN102018821A (en) | Chinese medicament for treating hypertrophic rachitis | |
| CN105012594A (en) | Traditional Chinese medicine for treating knee osteoarthritis | |
| CN106421255B (en) | External Chinese herbal medicine composition and application thereof | |
| CN109288900A (en) | A kind of Chinese medicine composition for treating treating rheumatic ostealgia | |
| CN109966451A (en) | A kind of Chinese medicine composition of bone-setting and pain-relieving | |
| CN109865010A (en) | The liquid medicine and preparation method thereof for treating rheumatic arthritis, osteoproliferation and protrusion of lumber intervertebral disc | |
| CN109010549A (en) | Synthetism expelling wind and activating blood flow pain relieving ointment and preparation method thereof | |
| CN103028022B (en) | Traditional Chinese medicine composition for treating arthralgia | |
| CN107095997A (en) | Rheumatic pain killing decoction | |
| CN103948679A (en) | External application for treating wind-cold-dampness arthritis | |
| CN105267411B (en) | A kind of pharmaceutical composition for treating fracture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191008 |